trending Market Intelligence /marketintelligence/en/news-insights/trending/6Z8VMZSQDtm5qH3-5BUDUQ2 content esgSubNav
In This List

Ohr Pharmaceutical closes upsized common stock, warrants offering

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Ohr Pharmaceutical closes upsized common stock, warrants offering

Ohr Pharmaceutical Inc. closed its public offering of common stock and warrants.

The company sold 3,885,000 common shares at a price of $2.00 per share. Investors also received series A warrants to purchase 1,942,500 common shares and series B warrants for 3,885,000 shares.

Ohr previously offered 3,875,000 common shares, series A warrants for 1,937,500 common shares and series B warrants for 3,875,000 common shares.

Series A warrants have a term of five years and an exercise price of $2.75 per share, and the series B warrants have a term of six months and an exercise price of $3.00 apiece. Both series of warrants are exercisable immediately.

The offering generated gross proceeds to the company of about $7.8 million, excluding proceeds from the exercise of warrants.

H.C. Wainwright & Co. LLC was the exclusive placement agent for the offering.